Ubs Group Ag Avidity Biosciences, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 177,876 shares of RNA stock, worth $5.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

177,876

Previous 104,383 70.41%

Holding current value

$5.66 Million

Previous $4.26 Million 91.58%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$37.21 - $48.14 $2.73 Million - $3.54 Million	73,493 Added 70.41%	177,876 $8.17 Million
Q2 2024 Aug 13, 2024	SELL	$22.73 - $40.85 $2.07 Million - $3.72 Million	-91,063 Reduced 46.59%	104,383 $4.26 Million
Q1 2024 May 13, 2024	BUY	$9.16 - $25.52 $10,030 - $27,944	1,095 Added 0.56%	195,446 $4.99 Million
Q4 2023 Feb 09, 2024	BUY	$4.87 - $9.37 $381,744 - $734,486	78,387 Added 67.6%	194,351 $1.76 Million
Q3 2023 Nov 09, 2023	SELL	$6.3 - $11.35 $422,742 - $761,607	-67,102 Reduced 36.65%	115,964 $739,000
Q2 2023 Aug 11, 2023	BUY	$10.62 - $17.34 $1.08 Million - $1.77 Million	101,832 Added 125.36%	183,066 $2.03 Million
Q1 2023 May 12, 2023	SELL	$15.35 - $25.65 $1.29 Million - $2.15 Million	-83,754 Reduced 50.76%	81,234 $1.25 Million
Q4 2022 Feb 08, 2023	BUY	$10.06 - $22.66 $1.38 Million - $3.11 Million	137,167 Added 493.03%	164,988 $3.66 Million
Q3 2022 Nov 10, 2022	SELL	$15.46 - $23.43 $204,968 - $310,634	-13,258 Reduced 32.27%	27,821 $455,000
Q2 2022 Aug 10, 2022	SELL	$11.18 - $20.5 $556,618 - $1.02 Million	-49,787 Reduced 54.79%	41,079 $597,000
Q1 2022 May 16, 2022	BUY	$14.2 - $23.78 $122,659 - $205,411	8,638 Added 10.5%	90,866 $1.68 Million
Q4 2021 Feb 14, 2022	BUY	$20.4 - $28.66 $908,656 - $1.28 Million	44,542 Added 118.19%	82,228 $1.96 Million
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $615,006 - $853,761	33,866 Added 886.54%	37,686 $928,000
Q2 2021 Aug 13, 2021	SELL	$19.62 - $29.26 $530,838 - $791,658	-27,056 Reduced 87.63%	3,820 $94,000
Q1 2021 May 12, 2021	BUY	$20.28 - $28.15 $587,694 - $815,758	28,979 Added 1527.62%	30,876 $673,000
Q4 2020 Feb 11, 2021	BUY	$24.73 - $35.12 $46,912 - $66,622	1,897 New	1,897 $49,000

Others Institutions Holding RNA

# of Institutions

255

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.66B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account